Association between uterine serous carcinoma and breast cancer

被引:38
|
作者
Gehrig, PA
Bae-Jump, VL
Boggess, JF
Groben, PA
Fowler, WC
Van Le, L
机构
[1] Univ N Carolina, Div Gynecol Oncol, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
endometrial cancer; breast cancer; tamoxifen;
D O I
10.1016/j.ygyno.2004.04.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Endometrial cancer and breast cancer are two common malignancies found in women. As a result of estrogen dependency, an association is thought to exist between these entities. This study was undertaken to determine if the endometrial carcinomas, which develop in women with a history of breast cancer, were more likely to be of the endometrioid or the serous histology, which is generally considered non-estrogen-dependent. Methods. A retrospective chart review was conducted for the years 1984-2001. All women who were diagnosed at our institution with endometrial carcinoma were identified. The women who also had a prior history of breast cancer were identified and comprise the cohort for this study. Information regarding age at diagnosis, tumor stage, histologic subtype, and tamoxifen exposure were recorded and analyzed. Results. About 1,166 women were diagnosed with endometrial cancer during the study period, of whom 54 (4.6%) had a pre-existing diagnosis of breast cancer. Of the 54 women in this study, 41 had tumors of the endometrioid histology and 13 had a tumor of the serous subtype. There was no difference with regards to median age at the time of diagnosis or years of tamoxifen exposure. Women with breast cancer were more likely to develop uterine serous carcinoma (USC) as compared to one of endometrioid histology (OR 2.6; 95% CI 1.29-5.23). Conclusions. Women with breast cancer who subsequently developed endometrial cancer exhibited a 2.6-fold increased risk of developing a USC as compared to an endometrioid carcinoma. These findings suggest that there may be an underlying genetic predisposition linking breast cancer and USC. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:208 / 211
页数:4
相关论文
共 50 条
  • [41] Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma
    Schmidt, Meirav
    Segev, Yakir
    Sadeh, Rotem
    Suzan, Erica
    Feferkorn, Ido
    Kaldawy, Anis
    Kligun, Gilit
    Lavie, Ofer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (07) : 1311 - 1317
  • [42] Is there an association between human immunodeficiency virus infection and breast cancer?
    Hamid Salim Shaaban
    Yashpal Modi
    Gunwant Guron
    Medical Oncology, 2012, 29 : 446 - 447
  • [43] Association between breast cancer subtypes and response to neoadjuvant anastrozole
    Dunbier, Anita K.
    Anderson, Helen
    Ghazoui, Zara
    Salter, Janine
    Parker, Joel S.
    Perou, Charles M.
    Smith, Ian E.
    Dowsett, Mitch
    STEROIDS, 2011, 76 (08) : 736 - 740
  • [44] Association between tamoxifen and tooth loss in women with breast cancer
    Felipe de Araujo Sensever
    Luísa Comerlato Jardim
    Kívia Linhares Ferrazzo
    Jovito Adiel Skupien
    Raquel Pippi Antoniazzi
    Supportive Care in Cancer, 2022, 30 : 8193 - 8199
  • [45] Molecular markers in uterine serous cancer: Correlation between endometrial biopsy and hysterectomy specimens
    Lokich, Elizabeth
    Kole, Martha
    Raker, Christina
    Quddus, M. Ruhul
    Mathews, Cara
    GYNECOLOGIC ONCOLOGY REPORTS, 2019, 29 : 98 - 101
  • [46] Association between tamoxifen and tooth loss in women with breast cancer
    Sensever, Felipe de Araujo
    Jardim, Luisa Comerlato
    Ferrazzo, Kivia Linhares
    Skupien, Jovito Adiel
    Antoniazzi, Raquel Pippi
    SUPPORTIVE CARE IN CANCER, 2022, 30 (10) : 8193 - 8199
  • [47] Is there an association between human immunodeficiency virus infection and breast cancer?
    Shaaban, Hamid Salim
    Modi, Yashpal
    Guron, Gunwant
    MEDICAL ONCOLOGY, 2012, 29 (02) : 446 - 447
  • [48] Uterine Serous Carcinoma and Uterine Carcinosarcoma: Molecular Features, Clinical Advances, and Emerging Therapies
    Lee, Elizabeth K.
    Liu, Joyce F.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 301 - 310
  • [49] HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma
    Mcnamara, Blair
    Mutlu, Levent
    Greenman, Michelle
    Harold, Justin
    Santin, Alessandro
    CANCERS, 2023, 15 (16)
  • [50] Combined modality therapy in the adjuvant treatment of uterine serous carcinoma
    Block, Alec M.
    Small, William, Jr.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (02)